On October 15, 2010, the Department of Defense (“DoD”) issued a final rule implementing Section 703 of the National Defense Authorization Act (“NDAA”). In this rule DoD takes the position that the NDAA requires pharmaceutical manufacturers to provide discounted drug prices based on the Veterans Health Care Act’s (“VHCA’s”) Federal Ceiling Price (“FCP”), for covered drugs … Continue Reading